Office Of Women's Health Gets Permanent Director
This article was originally published in The Pink Sheet Daily
Kathleen Uhl, team leader for the Pregnancy & Lactation Labeling Team, will replace Susan Wood.
You may also be interested in...
FDA Generics Office Gets Third Director In Three Workdays; Uhl Brings Policy, Pharmacology Experience
A long-time FDA veteran who remains largely unknown to the generics industry, Kathleen Uhl replaces CDER Director Janet Woodcock as acting director of the Office of Generic Drugs effective March 19 following Gregory Geba’s March 15 departure from the generic office’s top post.
Susan Wood says she can “no longer serve as staff when scientific and clinical evidence...has been overruled.”
Roche will consider requesting a re-examination of the negative decision by the Committee for Medicinal Products for Human Use.